Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Moleculin Biotech, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −5 vs. Q4 2023
- Shares held
- 258.5K
- −87.1K (−25.2%) vs. Q4 2023Converted for a 1-for-15 split
- Total value
- $1.53M
- −$2.91M (−65.6%) vs. Q4 2023
- New holders
- 3
- 8 more added
- Sold out
- 8
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 148,495 | $877.6K | 0.02% | −65,333−30.6% | ReducedConverted for a 1-for-15 split |
| Vanguard Group Inc | 75,300 | $445.0K | 0.00% | +3,292+4.6% | AddedConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 16,603 | $98.2K | 0.00% | +158+1.0% | AddedConverted for a 1-for-15 split |
| BlackRock Inc. | 12,473 | $73.7K | 0.00% | −122−1.0% | ReducedConverted for a 1-for-15 split |
| Atticus Wealth Management, LLC | 3,334 | $19.7K | 0.01% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Newbridge Financial Services Group, Inc. | 685 | $4.05K | 0.00% | +685 | New |
| Tower Research Capital LLC (TRC) | 621 | $3.67K | 0.00% | +141+29.4% | AddedConverted for a 1-for-15 split |
| Morgan Stanley | 423 | $2.50K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| FWL Investment Management, LLC | 278 | $1.64K | 0.00% | +278 | New |
| Sandy Spring Bank | 89 | $526 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Advisor Group Holdings, Inc. | 65 | $384 | 0.00% | +0+0.7% | AddedConverted for a 1-for-15 split |
| CVA Family Office, LLC | 34 | $201 | 0.00% | +1+2.0% | AddedConverted for a 1-for-15 split |
| Wells Fargo & Company | 19 | $112 | 0.00% | +4+24.5% | AddedConverted for a 1-for-15 split |
| North Star Investment Management Corp. | 16 | $95 | 0.00% | −1−4.0% | ReducedConverted for a 1-for-15 split |
| Bank of America Corp | 7 | $41 | 0.00% | −2−23.9% | ReducedConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 7 | $41 | 0.00% | +4+101.9% | AddedConverted for a 1-for-15 split |
| GWM Advisors LLC | 1 | $6 | 0.00% | +1+650.0% | AddedConverted for a 1-for-15 split |
| Royal Bank of Canada | 10 | $0 | 0.00% | −1,333−99.3% | ReducedConverted for a 1-for-15 split |
| NBC Securities, Inc. | 14 | – | – | +14 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −8,640−100.0% | Sold outConverted for a 1-for-15 split |
| State Street Corp | 0 | $0 | 0.00% | −4,760−100.0% | Sold outConverted for a 1-for-15 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,310−100.0% | Sold outConverted for a 1-for-15 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,573−100.0% | Sold outConverted for a 1-for-15 split |
| Schmidt P J Investment Management Inc | 0 | $0 | 0.00% | −1,933−100.0% | Sold outConverted for a 1-for-15 split |
| Jmac Enterprises LLC | 0 | $0 | 0.00% | −875−100.0% | Sold outConverted for a 1-for-15 split |
| Sigma Planning Corp | 0 | $0 | 0.00% | −800−100.0% | Sold outConverted for a 1-for-15 split |
| Hazlett, Burt & Watson, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold outConverted for a 1-for-15 split |